Announcements Trials

Browse Landscape

Status

Unknown 2 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 37 Carcinoma, Non-Small-Cell Lung 28 Glioblastoma 24 Brain Neoplasms 23 Esophageal Neoplasms 20 Rectal Neoplasms 19 Stomach Neoplasms 17 Glioma 17 Lung Neoplasms 16 Colorectal Neoplasms 16 Astrocytoma 14 Pancreatic Neoplasms 12 Central Nervous System Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 10 Neoplasm Metastasis 10 Head and Neck Neoplasms 10 Gliosarcoma 10 Sarcoma 9 Oligodendroglioma 9 Recurrence 8 Neoplasms 8 Adenocarcinoma Of Esophagus 8 Esophageal Squamous Cell Carcinoma 7 Uterine Cervical Neoplasms 6 Ovarian Neoplasms 6 Colonic Neoplasms 6 Pilonidal Sinus 5 Melanoma 5 Carcinoma, Ovarian Epithelial 5 Adenocarcinoma of Lung 5

Interventions

Microbial Collagenase 13 xiapex 10 Collagenases 4 Triamcinolone Acetonide 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Oxycodone 1 Injections, Intra-Articular 1 Ibuprofen 1 High-Energy Shock Waves 1 Enzymes 1 Arthroplasty, Replacement, Shoulder 1 Arthroplasty, Replacement, Elbow 1 Adalimumab 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Dupuytren Contracture × Surgical Procedures, Operative × Clear all

NCT01444729 2017-10-26

Post Approval Commitment Study

Endo Pharmaceuticals

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon ⚡